Cipla barred from selling cheaper version of Novartis drug by Delhi HC
Q. Name the Indian drug company engaged in production of generic drugs that was recently barred by the Delhi High Court from making or selling a cheaper copy of Novartis AG’s respiratory drug Onbrez domestically?- Published on 22 Jan 15a. Bharat Immunologicals & Biologicals Corpn. Ltd
b. Ambalal Sarabhai Enterprises Ltd
c. Coral Laboratories Ltd
d. Cipla Ltd
ANSWER: Cipla Ltd
Delhi High Court on 14th Jan’15 sought the response of Switzerland-based drug major Novartis AG on the plea of Indian pharma firm Cipla Ltd. against an order restraining it from making its respiratory disease drug, Indaflo, till it obtains a compulsory licence. Novartis has been selling the medicine in India as an inhalation powder and inhaler under the trademark name of "Onbrez" through its licencee Lupin Ltd, since 2010.
